In addition, RUNX1 mutations are also commonly found in a number of pre-leukemic diseases, such as myelodysplastic syndrome (MDS) and family platelet disorders (FPD), with predisposition to AML, showing RUNX1 mutation is an early event and the driving force to the cancer. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.